Table 2.
The TREM2 expression and clinicopathological variables association in groups.
| Characteristic | Low TREM2 expression | High TREM2 expression | p value |
|---|---|---|---|
| n | 234 | 234 | |
| Age, n (%) | 1.000 | ||
| ≤60 | 124 (27%) | 125 (27.2%) | |
| >60 | 106 (23%) | 105 (22.8%) | |
| Gender, n (%) | 0.342 | ||
| Female | 84 (17.9%) | 95 (20.3%) | |
| Male | 150 (32.1%) | 139 (29.7%) | |
| Race, n (%) | 0.771 | ||
| Asian | 7 (1.5%) | 5 (1.1%) | |
| Black or African American | 0 (0%) | 1 (0.2%) | |
| White | 222 (48.5%) | 223 (48.7%) | |
| BMI, n (%) | 0.050 | ||
| ≤25 | 53 (21.3%) | 31 (12.4%) | |
| >25 | 81 (32.5%) | 84 (33.7%) | |
| T stage, n (%) | 0.629 | ||
| T1 | 24 (6.6%) | 17 (4.7%) | |
| T2 | 40 (11.1%) | 38 (10.5%) | |
| T3 | 42 (11.6%) | 48 (13.3%) | |
| T4 | 80 (22.2%) | 72 (19.9%) | |
| N stage, n (%) | 0.297 | ||
| N0 | 119 (29%) | 115 (28%) | |
| N1 | 39 (9.5%) | 35 (8.5%) | |
| N2 | 18 (4.4%) | 31 (7.5%) | |
| N3 | 26 (6.3%) | 28 (6.8%) | |
| M stage, n (%) | 0.852 | ||
| M0 | 208 (47.3%) | 208 (47.3%) | |
| M1 | 11 (2.5%) | 13 (3%) |